Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BetterMe Rx vs NuuVim

BetterMe Rx
Graded #236

Lower grade

vs+6.199999999999989
NuuVim
Graded #101

Higher grade

The verdict

NuuVim takes it — 71.1/100 to 64.9/100.

NuuVim grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNuuVim +53
44
97
Dose & formulationNuuVim +21
75
96
Clinical oversightBetterMe Rx +42
84
42
Labs & monitoringBetterMe Rx +2
52
50
FulfillmentBetterMe Rx +27
88
61
Contract termsNuuVim +8
47
55
BetterMe Rx · left barNuuVim · right bar

The numbers

MetricBetterMe RxNuuVim
WeighScore64.9/10071.1/100
GradeCC
Scorecard rank#236#101
Semaglutide$199/mo (promotional rate, compounded)$79/mo (all doses, compounded)
Tirzepatide$299/mo (promotional rate, compounded)$133/mo (all doses, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesYes
BetterMe Rx

Graded #236 · C

Strengths

  • LegitScript verified
  • All 50 states coverage
  • Six named pharmacy partners with phone numbers — exceptional transparency
  • Both injectable and oral daily tablet formats for sema and tirz
  • Multi-month discounts (3-month and 6-month plans)

Where it loses points

  • No formal corporate entity name or address disclosed
  • Compounded only — no brand-name options
  • Broader platform (HRT, ED, NAD+, Sermorelin, skincare)
  • Headline $199/$299 are limited-time SALE prices; regular prices are $249/$349 per month
NuuVim

Graded #101 · C

Strengths

  • Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
  • Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
  • LegitScript Certified and HIPAA-compliant
  • Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
  • Operating legal entity disclosed: NuuVim LLC, Texas governing law

Where it loses points

  • No founder, CEO, medical director, or pharmacist-in-charge named
  • Refund and cancellation policy not surfaced on the site
  • Compounded medications are not FDA-approved
  • Doesn't disclose which pharmacy fills which drug or form
  • FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard